Coagulation factors and plasma proteins

Coagulation factors and plasma proteins represent a broad class of proteins essential for blood stability, vascular repair, and systemic transport. The coagulation factors, such as Factor X, Factor II (thrombin), and Factor VIII, function within a highly regulated enzymatic cascade to generate fibrin clots, preventing excessive blood loss after injury (StatPearls, 2023). Other plasma proteins like albumin maintain the blood's osmotic pressure and serve as carriers for various endogenous and exogenous molecules (NCBI, 2022). Pathological imbalances in these proteins can lead to life-threatening conditions, ranging from spontaneous hemorrhage in hemophilia to obstructive clots in deep vein thrombosis or stroke. Therapeutic strategies targeting these proteins are diverse, including anticoagulants that inhibit specific cascade steps to prevent thrombosis and replacement therapies that provide functional proteins to patients with hereditary deficiencies (PubMed, 2021). Because this term refers to a heterogeneous group of proteins rather than a single molecular entity, it is classified as a broad functional category in pharmacological contexts.

Other names

Blood clotting factorsHemostatic proteinsSerum proteinsCoagulation cascade componentsPlasma proteome

Drugs targeting this group act through various mechanisms including direct inhibition of specific serine proteases (e.g., Factor Xa or Thrombin), interference with the synthesis of vitamin K-dependent factors, or replacement of deficient proteins in patients with genetic disorders to restore the coagulation cascade.